CLNN

$0.00

(

0.00%

)
Quote details

stock

Clene Inc.

NASDAQ | CLNN

8.22

USD

$0.00

(

0.00%

)

At Close (As of Dec 3, 2025)

$95.69M

Market Cap

-

P/E Ratio

-3.23

EPS

$13.50

52 Week High

$2.28

52 Week Low

CONSUMER DEFENSIVE

Sector

CLNN Chart

Recent Chart
Price Action

CLNN Technicals

Tags:

CLNN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $272K
Total Revenue $342K
Cost Of Revenue $70K
Costof Goods And Services Sold $70K
Operating Income -$33M
Selling General And Administrative $13M
Research And Development $20M
Operating Expenses $33M
Investment Income Net -
Net Interest Income -$4M
Interest Income $865K
Interest Expense $4.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$39M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$35M
Ebitda -$34M
Net Income -$39M

Revenue & Profitability

Earnings Performance

CLNN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $27M
Total Current Assets $16M
Cash And Cash Equivalents At Carrying Value $12M
Cash And Short Term Investments $12M
Inventory $68K
Current Net Receivables $391K
Total Non Current Assets $11M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $3.5M
Other Non Current Assets -
Total Liabilities $36M
Total Current Liabilities $10M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $26M
Capital Lease Obligations $5.1M
Long Term Debt $15M
Current Long Term Debt $359K
Long Term Debt Noncurrent -
Short Long Term Debt Total $21M
Other Current Liabilities $5.1M
Other Non Current Liabilities -
Total Shareholder Equity -$8.9M
Treasury Stock -
Retained Earnings -$282M
Common Stock $1K
Common Stock Shares Outstanding $7M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$21M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $15K
Change In Receivables -
Change In Inventory -$31K
Profit Loss -
Cashflow From Investment $6.3M
Cashflow From Financing -$1.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$39M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $272K
Total Revenue $342K
Cost Of Revenue $70K
Costof Goods And Services Sold $70K
Operating Income -$33M
Selling General And Administrative $13M
Research And Development $20M
Operating Expenses $33M
Investment Income Net -
Net Interest Income -$4M
Interest Income $865K
Interest Expense $4.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$39M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$35M
Ebitda -$34M
Net Income -$39M

CLNN News

CLNN Profile

Clene Inc. Profile

Sector: CONSUMER DEFENSIVE

Industry: PACKAGED FOODS

Clene Inc. is a pioneering clinical-stage pharmaceutical company based in Salt Lake City, Utah, dedicated to developing innovative clean-surface nanotechnology (CSN) therapies targeting neurodegenerative diseases and other significant health challenges. With a commitment to conducting thorough clinical trials, Clene aims to secure regulatory approvals for its promising product pipeline, positioning itself as a potential leader in the biopharmaceutical sector. The company’s strong scientific foundation and forward-looking strategy align well with the interests of institutional investors seeking growth opportunities in the evolving healthcare landscape.

LPTX
+368.57%
$2.05
PAVS
-39.38%
$0.03
VRAX
+54.64%
$0.60
IXHL
+16.01%
$0.46
IRBT
+65.64%
$3.23
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.47%
$180.60
IPG
-1.95%
$24.57
ONDS
-5.20%
$7.64
AXDX
-61.36%
$0.03
NIO
-5.66%
$4.74
KITT
+53.62%
$1.11
PLUG
+4.02%
$2.19
TSLA
+2.97%
$442.03
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
BYND
-6.58%
$1.20
RR
+11.93%
$3.98
INTC
-0.07%
$43.43
BITF
-2.74%
$3.01
SOND
-23.45%
$0.12
CAPR
+359.90%
$29.25
QCLS
+30.02%
$4.39
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
IREN
+4.95%
$43.15
INHD
-9.37%
$0.13
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
MRVL
+3.97%
$96.58
NFLX
-5.40%
$103.43
BMNU
+7.56%
$7.89
BMNR
+3.63%
$33.07
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
AAL
+0.87%
$14.36
PFE
+1.92%
$25.63
MTSR
-0.35%
$70.50
PCG
-3.28%
$15.32
BBD
-2.22%
$3.58
HOOD
+2.19%
$125.95
F
+1.19%
$13.11
DNN
+1.73%
$2.63
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
IMRN
-11.89%
$1.53
PMAX
+23.73%
$2.80
CIFR
+4.00%
$18.34
HTOO
+8.85%
$3.81
GRYP
-10.38%
$1.38
CHR
-6.26%
$0.04
MODV
-25.22%
$0.43
MSFT
-1.56%
$482.34
QBTS
+2.12%
$22.97
CMND
-13.27%
$0.11
AMZN
-0.93%
$232.23
AAPL
+0.06%
$286.39
CCL
-0.34%
$25.84
AMD
+0.13%
$215.53
ASBP
-14.91%
$0.08
GOOGL
+1.35%
$320.08
PLTD
-1.79%
$6.83
KVUE
-0.17%
$16.83
PLTR
+1.93%
$173.99
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
PYPL
-2.46%
$61.35
CLSK
+0.83%
$13.82
AKTX
-14.10%
$0.34
BTBT
+1.33%
$2.26
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
RIG
+3.68%
$4.46
VIVK
-12.15%
$0.09
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
DVLT
-4.79%
$1.78
BAC
+1.52%
$54.00
CSCO
+1.09%
$76.87
WULF
-4.04%
$13.64
SAND
-6.04%
$12.12
PSTG
-26.52%
$69.59
M
+2.04%
$23.17
SHOT
-74.37%
$0.39
GTLB
-14.56%
$37.05
YGMZ
-14.61%
$0.07
CRCL
+9.63%
$84.90
ZAPP
-46.30%
$0.15
BMY
+5.39%
$50.85
KXIN
+28.38%
$3.98
CAN
-1.36%
$0.95
KOS
-3.60%
$1.07
NOK
+0.48%
$6.22
HBAN
+2.67%
$17.00
GRAB
-0.47%
$5.23
LPTX
+368.57%
$2.05
PAVS
-39.38%
$0.03
VRAX
+54.64%
$0.60
IXHL
+16.01%
$0.46
IRBT
+65.64%
$3.23
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.47%
$180.60
IPG
-1.95%
$24.57
ONDS
-5.20%
$7.64
AXDX
-61.36%
$0.03
NIO
-5.66%
$4.74
KITT
+53.62%
$1.11
PLUG
+4.02%
$2.19
TSLA
+2.97%
$442.03
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
BYND
-6.58%
$1.20
RR
+11.93%
$3.98
INTC
-0.07%
$43.43
BITF
-2.74%
$3.01
SOND
-23.45%
$0.12
CAPR
+359.90%
$29.25
QCLS
+30.02%
$4.39
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
IREN
+4.95%
$43.15
INHD
-9.37%
$0.13
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
MRVL
+3.97%
$96.58
NFLX
-5.40%
$103.43
BMNU
+7.56%
$7.89
BMNR
+3.63%
$33.07
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
AAL
+0.87%
$14.36
PFE
+1.92%
$25.63
MTSR
-0.35%
$70.50
PCG
-3.28%
$15.32
BBD
-2.22%
$3.58
HOOD
+2.19%
$125.95
F
+1.19%
$13.11
DNN
+1.73%
$2.63
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
IMRN
-11.89%
$1.53
PMAX
+23.73%
$2.80
CIFR
+4.00%
$18.34
HTOO
+8.85%
$3.81
GRYP
-10.38%
$1.38
CHR
-6.26%
$0.04
MODV
-25.22%
$0.43
MSFT
-1.56%
$482.34
QBTS
+2.12%
$22.97
CMND
-13.27%
$0.11
AMZN
-0.93%
$232.23
AAPL
+0.06%
$286.39
CCL
-0.34%
$25.84
AMD
+0.13%
$215.53
ASBP
-14.91%
$0.08
GOOGL
+1.35%
$320.08
PLTD
-1.79%
$6.83
KVUE
-0.17%
$16.83
PLTR
+1.93%
$173.99
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
PYPL
-2.46%
$61.35
CLSK
+0.83%
$13.82
AKTX
-14.10%
$0.34
BTBT
+1.33%
$2.26
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
RIG
+3.68%
$4.46
VIVK
-12.15%
$0.09
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
DVLT
-4.79%
$1.78
BAC
+1.52%
$54.00
CSCO
+1.09%
$76.87
WULF
-4.04%
$13.64
SAND
-6.04%
$12.12
PSTG
-26.52%
$69.59
M
+2.04%
$23.17
SHOT
-74.37%
$0.39
GTLB
-14.56%
$37.05
YGMZ
-14.61%
$0.07
CRCL
+9.63%
$84.90
ZAPP
-46.30%
$0.15
BMY
+5.39%
$50.85
KXIN
+28.38%
$3.98
CAN
-1.36%
$0.95
KOS
-3.60%
$1.07
NOK
+0.48%
$6.22
HBAN
+2.67%
$17.00
GRAB
-0.47%
$5.23

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.